1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン

1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン 価格

1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン 化学特性,用途語,生産方法

• 外観

  白色～ほとんど白色粉末～結晶

• 説明

  Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a potent inhibitor that blocks dopamine uptake (IC50 = 1-51 nM). It is more than 100-fold less effective at blocking serotonin or noradrenaline uptake. GBR 12909 effectively inhibits dopamine uptake in vivo, leading to consequent stimulation of dopamine receptors. GBR 12909 also inhibits pyrilamine binding to the histamine H1 receptor (IC50 = 18 nM) but poorly inhibits ligand binding to dopamine, adrenergic, acetylcholine, serotonin, and γ-aminobutyric acid receptors. It also blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM).

• 使用

  Vanoxerine dihydrochloride is a Dopamine reuptake inhibitor that is developed for treatment of Parkinson's disease and depression but has no effect on these diseases.

• 定義

  ChEBI: Vanoxerine dihydrochloride is a hydrochloride salt that is obtained by reaction of vanoxerine with two equivalents of hydrogen chloride. Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration. It has a role as a dopamine uptake inhibitor. It contains a vanoxerine(2+).

• 一般的な説明

  Vanoxerine dihydrochloride is a potent inhibitor of dopamine active transporter (DAT, Ki = 1 nM, IC50 = 40 and 51 nM) with >100 fold selectivity over noradrenalin and 5-HT re-uptake transporter. Shown to produce behavioral profile in mice for bipolar mania disease model and ADHD disease models.

• 危険性

  A poison.

• 生物活性

  Potent, competitive inhibitor of dopamine uptake (K i = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC 50 = 48 nM). Centrally active following systemic administration.

1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン 上流と下流の製品情報

1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン 生産企業

Global(125)Suppliers

1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン スペクトルデータ(¹HNMR)

67469-78-7, 1-[2-[ビス(4-フルオロフェニル)メトキシ]エチル]-4-(3-フェニルプロピル)ピペラジン キーワード